SAMHD1 and acute myeloid leukemia: In contrast, SAMHD1 depletion in the presence of HSP90 inhibitors was documented in various tumor cell types (Fig. 4e) and primary leukemia blasts derived from various AML patients (Figs. 3f and S3g), whose clinical information is provided in Supplementary Table 3.